05/29/2026
What if a simple blood test could detect pancreatic cancer before you ever had a symptom?
Researchers at Oregon Health & Science University (OHSU) may be closer than you think. Their liquid biopsy correctly identified 73% of pancreatic cancer patients — a disease that kills more than it should, largely because it’s often caught too late.
Liquid biopsies are one of the most exciting frontiers in cancer detection, but they come with real questions about accuracy, follow-up care, cost, and what a positive result actually means for patients.
This is how academic medicine , pushing the science forward while asking the hard questions.
More screenings are being developed and used to detect evidence of disease in bodily fluids. But questions remain about reliability and implications for care.